ID

41203

Description

A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE); ODM derived from: https://clinicaltrials.gov/show/NCT01414205

Link

https://clinicaltrials.gov/show/NCT01414205

Keywords

Versions (1)
  1. 7/12/20 7/12/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 12, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphocytic Leukemia, Chronic NCT01414205

English

Eligibility Lymphocytic Leukemia, Chronic NCT01414205

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
cluster of differentiation antigen 20 (cd20)-positive b-cell chronic lymphocytic leukemia [per international workshop on chronic lymphocytic leukemia (iwcll) guidelines]
Description

B-cell chronic lymphocytic leukemia CD20 positive

Data type

boolean

Alias
UMLS CUI [1,1]
C0475774
UMLS CUI [1,2]
C3888518
rai stage iii/iv or binet stage c disease, or rai stage i/ii or binet stage b disease that requires treatment according to iwcll guidelines
Description

Disease Rai Staging System | Disease Binet Staging System | Treatment required

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1514715
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C1511118
UMLS CUI [3]
C0332121
no previous treatment for cll chemotherapy, radiotherapy or immunotherapy; no previous rituximab treatment for autoimmune hemolytic anemia (aiha) or idiopathic thrombocytopenic purpura (itp); prior use of steroids for aiha or itp is allowed
Description

Chemotherapy Absent Chronic Lymphocytic Leukemia | Therapeutic radiology procedure Absent Chronic Lymphocytic Leukemia | Immunotherapy Absent Chronic Lymphocytic Leukemia | Rituximab Absent | Autoimmune hemolytic anemia | Acute idiopathic thrombocytopenic purpura

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0023434
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0023434
UMLS CUI [3,1]
C0021083
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0023434
UMLS CUI [4,1]
C0393022
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C0002880
UMLS CUI [6]
C0272292
eastern cooperative oncology group performance status of 0, 1 or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
transformation of cll to aggressive b-cell malignancy
Description

Transformation Chronic Lymphocytic Leukemia | Transformation Aggressive cancer B-cell

Data type

boolean

Alias
UMLS CUI [1,1]
C0040682
UMLS CUI [1,2]
C0023434
UMLS CUI [2,1]
C0040682
UMLS CUI [2,2]
C2945759
UMLS CUI [2,3]
C0004561
history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
Description

Allergic Reaction Severe Monoclonal Antibody Therapy | Anaphylaxis Severe Monoclonal Antibody Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0279694
UMLS CUI [2,1]
C0002792
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0279694
evidence of severe, uncontrolled concomitant disease
Description

Comorbidity Severe Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
known active infection or any major episode of infection requiring treatment with iv antibiotics or hospitalization within 4 weeks before the start of cycle 1
Description

Communicable Disease | Episode Major Communicable Disease | Requirement Antibiotics Intravenous | Hospitalization Required

Data type

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C0332189
UMLS CUI [2,2]
C0205164
UMLS CUI [2,3]
C0009450
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0003232
UMLS CUI [3,3]
C1522726
UMLS CUI [4]
C1708385
seropositive for human immunodeficiency virus (hiv)
Description

HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
positive for chronic hepatitis b infection (defined as positive hbsag serology)
Description

Chronic Hepatitis B Positive | Serology positive Hepatitis B Surface Antigens

Data type

boolean

Alias
UMLS CUI [1,1]
C0524909
UMLS CUI [1,2]
C1514241
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0019168
positive for hepatitis c (hepatitis c virus [hcv] antibody serology testing)
Description

Hepatitis C positive | Hepatitis C Antibodies Serologic tests

Data type

boolean

Alias
UMLS CUI [1]
C1112419
UMLS CUI [2,1]
C0166049
UMLS CUI [2,2]
C0036743
pregnant or lactating women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
concurrent (or within 7 days prior to fist dose of study treatment) systemic corticosteroid use, except for low-dose corticosteroid therapy used to treat illness other than lymphoma
Description

Systemic Corticosteroid Therapy | Exception Steroid therapy Low dose

Data type

boolean

Alias
UMLS CUI [1]
C4053960
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0149783
UMLS CUI [2,3]
C0445550
Back to the top of the page

Similar models

Eligibility Lymphocytic Leukemia, Chronic NCT01414205

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
B-cell chronic lymphocytic leukemia CD20 positive
Item
cluster of differentiation antigen 20 (cd20)-positive b-cell chronic lymphocytic leukemia [per international workshop on chronic lymphocytic leukemia (iwcll) guidelines]
boolean
C0475774 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
Disease Rai Staging System | Disease Binet Staging System | Treatment required
Item
rai stage iii/iv or binet stage c disease, or rai stage i/ii or binet stage b disease that requires treatment according to iwcll guidelines
boolean
C0012634 (UMLS CUI [1,1])
C1514715 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C1511118 (UMLS CUI [2,2])
C0332121 (UMLS CUI [3])
Chemotherapy Absent Chronic Lymphocytic Leukemia | Therapeutic radiology procedure Absent Chronic Lymphocytic Leukemia | Immunotherapy Absent Chronic Lymphocytic Leukemia | Rituximab Absent | Autoimmune hemolytic anemia | Acute idiopathic thrombocytopenic purpura
Item
no previous treatment for cll chemotherapy, radiotherapy or immunotherapy; no previous rituximab treatment for autoimmune hemolytic anemia (aiha) or idiopathic thrombocytopenic purpura (itp); prior use of steroids for aiha or itp is allowed
boolean
C0392920 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0023434 (UMLS CUI [2,3])
C0021083 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0023434 (UMLS CUI [3,3])
C0393022 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0002880 (UMLS CUI [5])
C0272292 (UMLS CUI [6])
ECOG performance status
Item
eastern cooperative oncology group performance status of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Transformation Chronic Lymphocytic Leukemia | Transformation Aggressive cancer B-cell
Item
transformation of cll to aggressive b-cell malignancy
boolean
C0040682 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
C0040682 (UMLS CUI [2,1])
C2945759 (UMLS CUI [2,2])
C0004561 (UMLS CUI [2,3])
Allergic Reaction Severe Monoclonal Antibody Therapy | Anaphylaxis Severe Monoclonal Antibody Therapy
Item
history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
boolean
C1527304 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0279694 (UMLS CUI [1,3])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0279694 (UMLS CUI [2,3])
Comorbidity Severe Uncontrolled
Item
evidence of severe, uncontrolled concomitant disease
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Communicable Disease | Episode Major Communicable Disease | Requirement Antibiotics Intravenous | Hospitalization Required
Item
known active infection or any major episode of infection requiring treatment with iv antibiotics or hospitalization within 4 weeks before the start of cycle 1
boolean
C0009450 (UMLS CUI [1])
C0332189 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
C1514873 (UMLS CUI [3,1])
C0003232 (UMLS CUI [3,2])
C1522726 (UMLS CUI [3,3])
C1708385 (UMLS CUI [4])
HIV Seropositivity
Item
seropositive for human immunodeficiency virus (hiv)
boolean
C0019699 (UMLS CUI [1])
Chronic Hepatitis B Positive | Serology positive Hepatitis B Surface Antigens
Item
positive for chronic hepatitis b infection (defined as positive hbsag serology)
boolean
C0524909 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019168 (UMLS CUI [2,2])
Hepatitis C positive | Hepatitis C Antibodies Serologic tests
Item
positive for hepatitis c (hepatitis c virus [hcv] antibody serology testing)
boolean
C1112419 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C0036743 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Systemic Corticosteroid Therapy | Exception Steroid therapy Low dose
Item
concurrent (or within 7 days prior to fist dose of study treatment) systemic corticosteroid use, except for low-dose corticosteroid therapy used to treat illness other than lymphoma
boolean
C4053960 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0149783 (UMLS CUI [2,2])
C0445550 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial